Showing results (281-290 of 16,630) with videos related to
Sort By:
Pageof 1,663
Cancer Letters|March 10, 2019
Forced expression of DYRK2 exerts anti-tumor effects via apoptotic induction in liver cancerShiho Yokoyama-Mashima, Satomi Yogosawa, Yumi Kanegae, et al.Cancer Letters|November 16, 2018
Zoledronic acid enhances the efficacy of the MEK inhibitor trametinib in KRAS mutant cancersXinyu Dai, Hongwei Xia, Sheng Zhou, et al.Cancer Letters|November 17, 2018
Mitosis perturbation by MASTL depletion impairs the viability of thyroid tumor cellsElena Cetti, Tiziana Di Marco, Giuseppe Mauro, et al.Cancer Letters|November 17, 2018
DNp73-induced degradation of tyrosinase links depigmentation with EMT-driven melanoma progressionKatharina Fürst, Marc Steder, Stella Logotheti, et al.Cancer Letters|February 22, 2019
A novel, liver-specific long noncoding RNA LINC01093 suppresses HCC progression by interaction with IGF2BP1 to facilitate decay of GLI1 mRNAJia He, Qiaozhu Zuo, Bo Hu, et al.Cancer Letters|January 1, 1986
Potentiation of 4'-(9-acridinylamino)methanesulphon-m-anisidine) action by verapamilS Darkin, R K RalphCancer Letters|February 27, 2019
HOX cluster-embedded antisense long non-coding RNAs in lung cancerLianlian Li, Yong Wang, Guoqiang Song, et al.Cancer Letters|November 19, 2018
Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer stem cells phenotypeYao Xiao, Yin Sun, Guodong Liu, et al.Cancer Letters|February 17, 2019
Towards the first targeted therapy for triple-negative breast cancer: Repositioning of clofazimine as a chemotherapy-compatible selective Wnt pathway inhibitorKamal Ahmed, Alexey Koval, Jiabin Xu, et al.Pageof 1,663